Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA is working closely with industry and local and federal officials to address the shortage situation for IV saline as a result of #HurricaneMaria. We expect the shortage of IV fluids will improve in early 2018 based on information we’re receiving from
SteveFDA (R-D.C.)
@SGottliebFDA
FDA believes strongly people addicted to opioids should have access to safe and effective treatments for addiction. Unfortunately, unscrupulous vendors are trying to capitalize on the opioid epidemic by illegally marketing products for these purposes htt
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA’s new Predictive Toxicology Roadmap and novel methods for toxicity testing will help us move safe products to market more efficiently; reduce reliance on animal testing for tox https://t.co/xOrLiU3vRJ
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA must encourage the development of tools that can help people be more informed about their health. We know our regulations play a crucial role in the innovation of #digitalhealth; 4 guidances released today provide greater clarity on our role https://
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA outlines a new approach to the development of drugs for a rare pediatric disease that could reduce the need fo… https://t.co/MyIHqRMwC7
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA’s public health mandate; gravity of opioid crisis compel us to take new steps to encourage more widespread inn… https://t.co/XiBVJXtoOt
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA taking new steps to promote innovation in products that can help smokers quit combustible cigarettes as part o… https://t.co/wsvREjfHly
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA began patent submission date data collection in 2013. There are now about 4,000 patent records for which submi… https://t.co/EGSP27iZFA
SteveFDA (R-D.C.)
@SGottliebFDA
My statement on new steps #FDA is taking today to promote development of generic versions of opioids formulated to… https://t.co/bEDmF5WA7i
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOncology: #PatientReportedOutcome measures to inform tolerability- PRO experts, international regulators, @theNCI & patients… https://t.co/1EE5cK1JbV
SteveFDA (R-D.C.)
@SGottliebFDA
RT @NYTHealth: The F.D.A. speeds review of some gene, cell therapies, a move desired by the industry. Critics want more oversight. https://t.co/qVlNGGB5u0
SteveFDA (R-D.C.)
@SGottliebFDA
(3/3) As commissioner, I’m personally committed to this effort. It’s one of my highest priorities. In collaboration… https://t.co/4Gb3YksCDO
SteveFDA (R-D.C.)
@SGottliebFDA
Reason Magazine: The #FDA Will Finally Let You See Your Genetic Information https://t.co/DICx5hTM6M
SteveFDA (R-D.C.)
@SGottliebFDA
RT @CBSNews: Doctors urge flu shot ahead of what could be rough season https://t.co/RahLmGLlnV https://t.co/33yeFC6Gjs
SteveFDA (R-D.C.)
@SGottliebFDA
RT @DrugChannels: From @RAPSorg: Summary of @SGottliebFDA @FTC comments about "shenanigans" delaying #generic #drug competition https://t.co/4ZS3pbfa2I
SteveFDA (R-D.C.)
@SGottliebFDA
RT @wtimesnation: FDA chief Scott Gottlieb says opioids fight must tackle stigma around treatment https://t.co/0FwRcuGbQi
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA launches new, comprehensive campaign promoting use of #biosimilars through education, information for providers https://t.co/mjYhTwx0vS
SteveFDA (R-D.C.)
@SGottliebFDA
FDA watching for med-tech shortages in wake of Puerto Rico power grid failure: https://t.co/4g2hZ2ofNx